Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

VALSARTAN Drug Profile

« Back to Dashboard

Which patents cover Valsartan, and when can generic versions of Valsartan launch?

Valsartan is a drug marketed by Amneal Pharms, Hetero Labs Ltd V, Prinston Inc, Aurobindo Pharma Ltd, Torrent Pharms Ltd, Ivax Pharms, Jubilant Generics, Watson Labs Inc, Mylan Pharms Inc, Alembic Pharms Ltd, Lupin Ltd, Ohm Labs Inc, Macleods Pharms Ltd, Apotex Inc, and Alembic Ltd. and is included in twenty-one NDAs.

The generic ingredient in VALSARTAN is hydrochlorothiazide; valsartan. There are thirty-one drug master file entries for this compound. Thirty suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.

Summary for Tradename: VALSARTAN

Patents:0
Applicants:15
NDAs:21
Suppliers / Packagers: see list32
Bulk Api Vendors: see list84
Clinical Trials: see list67
Patent Applications: see list5,102
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VALSARTAN at DailyMed

Pharmacology for Tradename: VALSARTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL203026-005Mar 21, 2013ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
VALSARTAN
valsartan
TABLET;ORAL201677-001Jan 5, 2015ABRXNoNo► Subscribe► Subscribe
Watson Labs Inc
VALSARTAN
valsartan
TABLET;ORAL090642-004Jan 5, 2015ABRXNoNo► Subscribe► Subscribe
Alembic Ltd
VALSARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; valsartan
TABLET;ORAL201662-004Mar 21, 2013ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
VALSARTAN
valsartan
TABLET;ORAL202696-001Sep 16, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot